Form 8-K - Current report:
SEC Accession No. 0001213900-23-094884
Filing Date
2023-12-12
Accepted
2023-12-12 08:02:25
Documents
15
Period of Report
2023-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189864-8k_intensity.htm   iXBRL 8-K 37145
2 EMPLOYMENT AGREEMENT WITH JOSEPH TALAMO ea189864ex10-1_intensity.htm EX-10.1 93438
3 PRESS RELEASE, DATED DECEMBER 12, 2023 ea189864ex99-1_intensity.htm EX-99.1 16674
4 GRAPHIC ex99-1_001.jpg GRAPHIC 4474
  Complete submission text file 0001213900-23-094884.txt   355586

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ints-20231211.xsd EX-101.SCH 3054
6 XBRL LABEL FILE ints-20231211_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ints-20231211_pre.xml EX-101.PRE 22385
9 EXTRACTED XBRL INSTANCE DOCUMENT ea189864-8k_intensity_htm.xml XML 3422
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 231479996
SIC: 2836 Biological Products, (No Diagnostic Substances)